Glofitamab in refractory Burkitt lymphoma-type post-transplant lymphoproliferative disorder. Lam HPJ, Arulogun S, Mikhaeel NG, Brady JL, et al. Br J Haematol 2026 Apr 28. doi: 10.1111/bjh.70519.

Read + Share

Amedeo Smart

Independent Medical Education

Lam HPJ, Arulogun S, Mikhaeel NG, Brady JL, et al. Glofitamab in refractory Burkitt lymphoma-type post-transplant lymphoproliferative disorder. Br J Haematol 2026 Apr 28. doi: 10.1111/bjh.70519.
PMID: 42049201